1
|
van Belkum SM, Opmeer EM, Geugies H, de Boer MK, Schoevers RA, Aleman A. Change in brain activation after transcranial pulsed electromagnetic fields in treatment-resistant depression. Eur Arch Psychiatry Clin Neurosci 2024:10.1007/s00406-024-01797-w. [PMID: 38580858 DOI: 10.1007/s00406-024-01797-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/20/2023] [Accepted: 03/09/2024] [Indexed: 04/07/2024]
Abstract
BACKGROUND Preliminary evidence suggests antidepressant effects of transcranial pulsed electromagnetic fields (tPEMF). However, the precise mechanism of action in the brain is still unknown. The aim of this study was to investigate the influence of tPEMF on brain activation in patients with treatment-resistant depression (TRD) by studying two processes that might be of particular interest in relation to the symptoms of depression: emotional processing and reward processing. METHODS Eligible participants (n = 50) with TRD in this sham-controlled double-blind multicenter trial [registered at the Dutch Trial Register ( http://www.trialregister.nl ), NTR3702] were randomly assigned to five weeks daily active or sham tPEMF. Pre- and post-treatment functional MR-scans were made during which participants performed a social-emotional task and a reward task. RESULTS Participants in the active treatment group showed a stronger decrease in activation post-treatment compared to sham during reward-outcome processing in the left inferior frontal gyrus and in a cluster comprising the right lingual gyrus and the posterior part of the middle temporal gyrus. No effect of tPEMF was found on activation during the social-emotional task. Neurostimulation with tPEMF did also not affect behavioral performance for both tasks. CONCLUSIONS We found a decrease in reward-related activation as a result of tPEMF stimulation, while no effect of tPEMF on social-emotional processing was found. The treatment-related reduction in activation of regulatory regions may reflect normalization and may have implications for anhedonia. These findings suggest that there is an effect of tPEMF on brain activation of relevant circuits, albeit in the absence of a clinical antidepressant effect.
Collapse
Affiliation(s)
- Sjoerd M van Belkum
- Department of Psychiatry, Research School of Behavioral and Cognitive Neurosciences (BCN), Interdisciplinary Center Psychopathology of Emotion Regulation (ICPE), University Medical Center Groningen, University of Groningen, PO Box 30.001 (CC30), 9700 RB, Groningen, The Netherlands.
- Department of Neuroscience, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
| | - Esther M Opmeer
- Department of Neuroscience, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
| | - Hanneke Geugies
- Department of Psychiatry, Research School of Behavioral and Cognitive Neurosciences (BCN), Interdisciplinary Center Psychopathology of Emotion Regulation (ICPE), University Medical Center Groningen, University of Groningen, PO Box 30.001 (CC30), 9700 RB, Groningen, The Netherlands
| | - Marrit K de Boer
- Department of Psychiatry, Research School of Behavioral and Cognitive Neurosciences (BCN), Interdisciplinary Center Psychopathology of Emotion Regulation (ICPE), University Medical Center Groningen, University of Groningen, PO Box 30.001 (CC30), 9700 RB, Groningen, The Netherlands
| | - Robert A Schoevers
- Department of Psychiatry, Research School of Behavioral and Cognitive Neurosciences (BCN), Interdisciplinary Center Psychopathology of Emotion Regulation (ICPE), University Medical Center Groningen, University of Groningen, PO Box 30.001 (CC30), 9700 RB, Groningen, The Netherlands
| | - André Aleman
- Department of Neuroscience, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
| |
Collapse
|
2
|
Lejko N, Tumati S, Opmeer EM, Marsman JBC, Reesink FE, De Deyn PP, Aleman A, Ćurčić-Blake B. Planning in amnestic mild cognitive impairment: an fMRI study. Exp Gerontol 2021; 159:111673. [PMID: 34958871 DOI: 10.1016/j.exger.2021.111673] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2021] [Revised: 11/24/2021] [Accepted: 12/17/2021] [Indexed: 11/25/2022]
Abstract
INTRODUCTION The memory impairment that is characteristic of amnestic mild cognitive impairment (aMCI) is often accompanied by difficulties in executive functioning, including planning. Though planning deficits in aMCI are well documented, their neural correlates are largely unknown, and have not yet been investigated with functional magnetic resonance imaging (fMRI). OBJECTIVES The aim of this study was to: (1) identify differences in brain activity and connectivity during planning in people with aMCI and cognitively healthy older adults, and (2) find whether planning-related activity and connectivity are associated with cognitive performance and symptoms of apathy. METHODS Twenty-five people with aMCI and 15 cognitively healthy older adults performed a visuospatial planning task (Tower of London; ToL) during fMRI. Task-related brain activation, spatial maps of task-related independent components, and seed-to-voxel functional connectivity were compared between the two groups and regressed against measures of executive functions (Trail Making Test difference score, TMT B-A; Digit Symbol Substitution Test, DSST), delayed recall (Rey Auditory Verbal Learning Test), and apathy (Apathy Evaluation Scale). RESULTS People with aMCI scored lower on task-switching (TMT B-A), working memory (DSST), and planning (ToL). During planning, people with aMCI had less activation in the bilateral anterior calcarine sulcus/cuneus, the bilateral temporal cortices, the left precentral gyrus, the thalamus, and the right cerebellum. Across all participants, higher planning-related activity in the supplementary motor area, the retrosplenial cortex and surrounding areas, and the right temporal cortex was related to better delayed recall. There were no between-group differences in functional connectivity, nor were there any associations between connectivity and cognition. We also did not find any associations between brain activity or connectivity and apathy. CONCLUSION Impaired planning in people with aMCI appears to be accompanied by lower activation in a diffuse cortico-thalamic network. Across all participants, higher planning-related activity in parieto-occipital, temporal, and frontal areas was related to better memory performance. The results point to the relevance of planning deficits for understanding aMCI and extend its clinical and neurobiological signature.
Collapse
Affiliation(s)
- Nena Lejko
- University of Groningen, University Medical Center Groningen, Department of Biomedical Sciences of Cells & Systems, Cognitive Neuroscience Center, Groningen, the Netherlands.
| | - Shankar Tumati
- University of Groningen, University Medical Center Groningen, Department of Biomedical Sciences of Cells & Systems, Cognitive Neuroscience Center, Groningen, the Netherlands; Neuropsychopharmacology Research Group, Sunnybrook Research Institute, Toronto, Ontario, Canada
| | - Esther M Opmeer
- University of Groningen, University Medical Center Groningen, Department of Biomedical Sciences of Cells & Systems, Cognitive Neuroscience Center, Groningen, the Netherlands; Windesheim University of Applied Sciences, Department of Health and Welfare, Zwolle, the Netherlands
| | - Jan-Bernard C Marsman
- University of Groningen, University Medical Center Groningen, Department of Biomedical Sciences of Cells & Systems, Cognitive Neuroscience Center, Groningen, the Netherlands
| | - Fransje E Reesink
- Department of Neurology and Alzheimer Center Groningen, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
| | - Peter P De Deyn
- Department of Neurology and Alzheimer Center Groningen, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium
| | - André Aleman
- University of Groningen, University Medical Center Groningen, Department of Biomedical Sciences of Cells & Systems, Cognitive Neuroscience Center, Groningen, the Netherlands; Shenzhen Key Laboratory of Affective and Social Neuroscience, Center for Brain Disorders and Cognitive Sciences, Shenzhen University, Shenzhen, China
| | - Branislava Ćurčić-Blake
- University of Groningen, University Medical Center Groningen, Department of Biomedical Sciences of Cells & Systems, Cognitive Neuroscience Center, Groningen, the Netherlands
| |
Collapse
|
3
|
Lejko N, Tumati S, Opmeer EM, Marsman JC, Reesink FE, De Deyn PP, Aleman A, Ćurčić‐Blake B. Neural correlates of executive functions in people with amnestic mild cognitive impairment. Alzheimers Dement 2021. [DOI: 10.1002/alz.053032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- Nena Lejko
- University of Groningen University Medical Center Groningen Groningen Netherlands
| | - Shankar Tumati
- University of Groningen University Medical Center Groningen Groningen Netherlands
- Neuropsychopharmacology Research Group Sunnybrook Research Institute Toronto ON Canada
| | - Esther M. Opmeer
- University of Groningen University Medical Center Groningen Groningen Netherlands
| | | | - Fransje E. Reesink
- University of Groningen University Medical Center Groningen Groningen Netherlands
| | - Peter Paul De Deyn
- University of Groningen University Medical Center Groningen Groningen Netherlands
- Institute Born‐Bunge University of Antwerp Antwerp Belgium
| | - André Aleman
- University of Groningen University Medical Center Groningen Groningen Netherlands
| | | |
Collapse
|
4
|
van Belkum SM, de Boer MK, Opmeer EM, Kortekaas R, Mulder T, Woonings F, Hoenders HJR, Kamphuis H, Aleman A, Schoevers RA. No antidepressant effects of low intensity transcranial pulsed electromagnetic fields for treatment resistant depression. J Affect Disord 2021; 294:679-685. [PMID: 34333176 DOI: 10.1016/j.jad.2021.07.087] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/24/2021] [Revised: 04/15/2021] [Accepted: 07/15/2021] [Indexed: 11/18/2022]
Abstract
BACKGROUND Noninvasive neurostimulation with transcranial Pulsed Electromagnetic Fields (tPEMF) may be a promising method for treatment resistant depression (TRD). Studies shown substantial improvement of depressive symptoms in patients with TRD, but there is no information on long-term antidepressant effects. The aim of this study was to investigate the short- and long-term efficacy of tPEMF in participants with TRD. METHODS Eligible participants with TRD in this sham-controlled double-blind multicenter trial were randomly assigned to five weeks either daily active or sham tPEMF. Severity of depression and anxiety was assessed pre- and directly post-treatment and five and fifteen weeks post-treatment. Primary outcome was change on the 17-item Hamilton depression rating scale directly post-treatment. Secondary outcome was change on the Hamilton-17 during follow-up and change on the Inventory of Depressive Symptomatology Self-Report and the Beck Anxiety Index. RESULTS Of the 55 included participants, 50 completed the treatment protocol. Depressive symptoms improved over time in both groups. The improvement continued until the last follow-up measure. There was no difference in outcome between the active and the sham group on change in depression post-treatment or on any secondary measure. CONCLUSION Treatment with this type of active tPEMF was not superior to sham in patients with TRD. This is in contrast to a previous study using a similar design and power calculation, but a higher magnetic field strength, that reported improvement of depression after treatment with tPEMF compared to sham. An important limitation of our study was the fact that no different dosing regimens were tried.
Collapse
Affiliation(s)
- Sjoerd M van Belkum
- University of Groningen, University Medical Center Groningen, Department of Psychiatry, Research School of Behavioral and Cognitive Neurosciences (BCN), Interdisciplinary Center Psychopathology of Emotion regulation (ICPE), the Netherlands.; University of Groningen, University Medical Center Groningen, Department of Neuroscience, the Netherlands..
| | - Marrit K de Boer
- University of Groningen, University Medical Center Groningen, Department of Psychiatry, Research School of Behavioral and Cognitive Neurosciences (BCN), Interdisciplinary Center Psychopathology of Emotion regulation (ICPE), the Netherlands
| | - Esther M Opmeer
- University of Groningen, University Medical Center Groningen, Department of Neuroscience, the Netherlands
| | - Rudie Kortekaas
- University of Groningen, University Medical Center Groningen, Department of Neuroscience, the Netherlands
| | - Tim Mulder
- University of Groningen, University Medical Center Groningen, Department of Neuroscience, the Netherlands
| | | | | | - Hans Kamphuis
- University of Groningen, University Medical Center Groningen, Department of Psychiatry, Research School of Behavioral and Cognitive Neurosciences (BCN), Interdisciplinary Center Psychopathology of Emotion regulation (ICPE), the Netherlands.; University of Groningen, University Medical Center Groningen, Department of Neuroscience, the Netherlands.; GGZ Drenthe, the Netherlands,; Lentis, Center for Integrative Psychiatry, the Netherlands.; PsyQ Groningen, the Netherlands
| | - André Aleman
- University of Groningen, University Medical Center Groningen, Department of Neuroscience, the Netherlands
| | - Robert A Schoevers
- University of Groningen, University Medical Center Groningen, Department of Psychiatry, Research School of Behavioral and Cognitive Neurosciences (BCN), Interdisciplinary Center Psychopathology of Emotion regulation (ICPE), the Netherlands
| |
Collapse
|
5
|
Larabi DI, Marsman JBC, Aleman A, Tijms BM, Opmeer EM, Pijnenborg GHM, van der Meer L, van Tol MJ, Ćurčić-Blake B. Insight does not come at random: Individual gray matter networks relate to clinical and cognitive insight in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2021; 109:110251. [PMID: 33493651 DOI: 10.1016/j.pnpbp.2021.110251] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/13/2020] [Revised: 12/11/2020] [Accepted: 01/13/2021] [Indexed: 12/28/2022]
Abstract
BACKGROUND Impaired clinical and cognitive insight are prevalent in schizophrenia and relate to poorer outcome. Good insight has been suggested to depend on social cognitive and metacognitive abilities requiring global integration of brain signals. Impaired insight has been related to numerous focal gray matter (GM) abnormalities distributed across the brain suggesting dysconnectivity at the global level. In this study, we test whether global integration deficiencies reflected in gray matter network connectivity underlie individual variations in insight. METHODS We used graph theory to examine whether individual GM-network metrics relate to insight in patients with a psychotic disorder (n = 114). Clinical insight was measured with the Schedule for the Assessment of Insight-Expanded and item G12 of the Positive and Negative Syndrome Scale, and cognitive insight with the Beck Cognitive Insight Scale. Individual GM-similarity networks were created from GM-segmentations of T1-weighted MRI-scans. Graph metrics were calculated using the Brain Connectivity Toolbox. RESULTS Networks of schizophrenia patients with poorer clinical insight showed less segregation (i.e. clustering coefficient) into specialized subnetworks at the global level. Schizophrenia patients with poorer cognitive insight showed both less segregation and higher connectedness (i.e. lower path length) of their brain networks, making their network topology more "random". CONCLUSIONS Our findings suggest less segregated processing of information in patients with poorer cognitive and clinical insight, in addition to higher connectedness in patients with poorer cognitive insight. The ability to take a critical perspective on one's symptoms (clinical insight) or views (cognitive insight) might depend especially on segregated specialized processing within distinct subnetworks.
Collapse
Affiliation(s)
- Daouia I Larabi
- Department of Biomedical Sciences of Cells and Systems, Cognitive Neuroscience Center, University of Groningen, University Medical Center Groningen, Antonius Deusinglaan 2, 9713 AW Groningen, the Netherlands; Institute of Neuroscience and Medicine, Brain & Behaviour (INM-7), Research Centre Jülich, Wilhelm-Johnen-Straße, 52428 Jülich, Germany; Institute of Systems Neuroscience, Medical Faculty, Heinrich Heine University Düsseldorf, Gurlittstraße 55, 40223 Düsseldorf, Germany.
| | - Jan-Bernard C Marsman
- Department of Biomedical Sciences of Cells and Systems, Cognitive Neuroscience Center, University of Groningen, University Medical Center Groningen, Antonius Deusinglaan 2, 9713 AW Groningen, the Netherlands
| | - André Aleman
- Department of Biomedical Sciences of Cells and Systems, Cognitive Neuroscience Center, University of Groningen, University Medical Center Groningen, Antonius Deusinglaan 2, 9713 AW Groningen, the Netherlands; Department of Clinical and Developmental Neuropsychology, University of Groningen, Grote Kruisstraat 2/1, 9712 TS Groningen, the Netherlands
| | - Betty M Tijms
- Alzheimer Center and Department of Neurology, Amsterdam Neuroscience, Amsterdam University Medical Center, PO Box 7057, 1007 MB Amsterdam, the Netherlands
| | - Esther M Opmeer
- Department of Biomedical Sciences of Cells and Systems, Cognitive Neuroscience Center, University of Groningen, University Medical Center Groningen, Antonius Deusinglaan 2, 9713 AW Groningen, the Netherlands; Department of Health and Welfare, University of Applied Sciences Windesheim, Campus 2, 8017 CA Zwolle, the Netherlands
| | - Gerdina H M Pijnenborg
- Department of Clinical and Developmental Neuropsychology, University of Groningen, Grote Kruisstraat 2/1, 9712 TS Groningen, the Netherlands; Department of Psychotic Disorders, GGZ Drenthe, Dennenweg 9, 9404 LA Assen, the Netherlands
| | - Lisette van der Meer
- Department of Clinical and Developmental Neuropsychology, University of Groningen, Grote Kruisstraat 2/1, 9712 TS Groningen, the Netherlands; Department of Psychiatric Rehabilitation, Lentis Psychiatric Institute, Lagerhout E35, 9741 KE Zuidlaren, the Netherlands; Rob Giel Research Center, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, the Netherlands
| | - Marie-José van Tol
- Department of Biomedical Sciences of Cells and Systems, Cognitive Neuroscience Center, University of Groningen, University Medical Center Groningen, Antonius Deusinglaan 2, 9713 AW Groningen, the Netherlands
| | - Branislava Ćurčić-Blake
- Department of Biomedical Sciences of Cells and Systems, Cognitive Neuroscience Center, University of Groningen, University Medical Center Groningen, Antonius Deusinglaan 2, 9713 AW Groningen, the Netherlands
| |
Collapse
|
6
|
Setiadi TM, Martens S, Opmeer EM, Marsman JBC, Tumati S, Reesink FE, De Deyn PP, Aleman A, Ćurčić-Blake B. Widespread white matter aberration is associated with the severity of apathy in amnestic Mild Cognitive Impairment: Tract-based spatial statistics analysis. Neuroimage Clin 2021; 29:102567. [PMID: 33545500 PMCID: PMC7856325 DOI: 10.1016/j.nicl.2021.102567] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/11/2020] [Revised: 01/04/2021] [Accepted: 01/12/2021] [Indexed: 02/06/2023]
Abstract
In aMCI, apathy severity was associated with lower FA in widespread WM pathways. WM aberrations are related to apathy severity after controlling for depression. Disruptions related to apathy severity are not limited to frontal-subcortical area.
Apathy is recognized as a prevalent behavioral symptom of amnestic Mild Cognitive Impairment (aMCI). In aMCI, apathy is associated with an increased risk and increases the risk of progression to Alzheimer’s Disease (AD). Previous DTI study in aMCI showed that apathy has been associated with white matter alterations in the cingulum, middle and inferior longitudinal fasciculus, fornix, and uncinate fasciculus. However, the underlying white matter correlates associated with apathy in aMCI are still unclear. We investigated this relationship using whole-brain diffusion tensor imaging (DTI). Twenty-nine aMCI patients and 20 matched cognitively healthy controls were included. Apathy severity was assessed using the Apathy Evaluation Scale Clinician version. We applied the tract-based spatial statistics analyses to DTI parameters: fractional anisotropy (FA), mean diffusivity, axial diffusivity, and radial diffusivity to investigate changes in white matter pathways associated with the severity of apathy. No significant difference was found in any of the DTI parameters between aMCI and the control group. In aMCI, higher severity of apathy was associated with lower FA in various white matter pathways including the left anterior part of inferior fronto-occipital fasciculus/uncinate fasciculus, genu and body of the corpus callosum, superior and anterior corona radiata, anterior thalamic radiation of both hemispheres and in the right superior longitudinal fasciculus/anterior segment of arcuate fasciculus (p < .05, TFCE-corrected) after controlling for age, gender and GDS non-apathy. A trend association was observed in the right posterior corona radiata and corticospinal tract/internal capsule, and bilateral forceps minor (p < .065, TFCE-corrected). In conclusion, in aMCI, severity of apathy is associated with aberrant white matter integrity in widely distributed pathways, within and between hemispheres.
Collapse
Affiliation(s)
- Tania M Setiadi
- Cognitive Neuroscience Center, Department of Biomedical Sciences of Cells & Systems, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
| | - Sander Martens
- Cognitive Neuroscience Center, Department of Biomedical Sciences of Cells & Systems, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
| | - Esther M Opmeer
- Cognitive Neuroscience Center, Department of Biomedical Sciences of Cells & Systems, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Department of Health and Welfare, Windesheim University of Applied Science, Zwolle, The Netherlands
| | - Jan-Bernard C Marsman
- Cognitive Neuroscience Center, Department of Biomedical Sciences of Cells & Systems, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
| | - Shankar Tumati
- Cognitive Neuroscience Center, Department of Biomedical Sciences of Cells & Systems, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Sunnybrook Research Institute and University of Toronto, Toronto, ON, Canada
| | - Fransje E Reesink
- Department of Neurology, Alzheimer Center Groningen, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
| | - Peter P De Deyn
- Department of Neurology, Alzheimer Center Groningen, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium
| | - André Aleman
- Cognitive Neuroscience Center, Department of Biomedical Sciences of Cells & Systems, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Department of Psychology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
| | - Branislava Ćurčić-Blake
- Cognitive Neuroscience Center, Department of Biomedical Sciences of Cells & Systems, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
| |
Collapse
|
7
|
van der Stouwe ECD, Pijnenborg GHM, Opmeer EM, de Vries B, Marsman JBC, Aleman A, van Busschbach JT. Neural changes following a body-oriented resilience therapy with elements of kickboxing for individuals with a psychotic disorder: a randomized controlled trial. Eur Arch Psychiatry Clin Neurosci 2021; 271:355-366. [PMID: 31980899 PMCID: PMC7960594 DOI: 10.1007/s00406-020-01097-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/03/2019] [Accepted: 01/13/2020] [Indexed: 11/27/2022]
Abstract
Individuals with a psychotic disorder are at an increased risk of becoming the victim of a crime. A body-oriented resilience therapy (BEATVIC) aimed at preventing victimization by addressing putatively underlying factors was developed. One of these factors is social cognition, particularly facial affect processing. The current study investigated neural effects of BEATVIC on facial affect processing using two face processing tasks. Participants were randomized to either BEATVIC or a 'Befriending' control group. Twenty-seven patients completed an Emotional Faces task and the Wall of Faces task during fMRI, pre- and post-intervention. General linear model analyses yielded no differences between groups over time. Independent component analyses revealed increased activation of the salience network to angry and fearful faces in BEATVIC compared to Befriending. Increased activation of the salience network may suggest an increased alertness for potentially dangerous faces.
Collapse
Affiliation(s)
- Elisabeth C D van der Stouwe
- University of Groningen, University Medical Center Groningen, University Center of Psychiatry, Rob Giel Onderzoekcentrum, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.
- Department of Neuroscience, Cognitive Neuroscience Center, University of Groningen, University Medical Center Groningen, Antonius Deusinglaan 2, 9713 AW, Groningen, The Netherlands.
| | - Gerdina H M Pijnenborg
- Department of Clinical Psychology, University of Groningen, Grote Kruisstraat 2/1, 9712 TS, Groningen, The Netherlands
- Department of Psychotic Disorders, GGZ-Drenthe, Dennenweg 9, 9404 LA, Assen, The Netherlands
| | - Esther M Opmeer
- Department of Neuroscience, Cognitive Neuroscience Center, University of Groningen, University Medical Center Groningen, Antonius Deusinglaan 2, 9713 AW, Groningen, The Netherlands
- Department of Health and Social Work, Windesheim University of Applied Sciences, Campus 2-6, 8017 CA, Zwolle, The Netherlands
| | - Bertine de Vries
- Department of Clinical Psychology, University of Groningen, Grote Kruisstraat 2/1, 9712 TS, Groningen, The Netherlands
| | - Jan-Bernard C Marsman
- Department of Neuroscience, Cognitive Neuroscience Center, University of Groningen, University Medical Center Groningen, Antonius Deusinglaan 2, 9713 AW, Groningen, The Netherlands
| | - André Aleman
- Department of Neuroscience, Cognitive Neuroscience Center, University of Groningen, University Medical Center Groningen, Antonius Deusinglaan 2, 9713 AW, Groningen, The Netherlands
- Department of Clinical Psychology, University of Groningen, Grote Kruisstraat 2/1, 9712 TS, Groningen, The Netherlands
| | - Jooske T van Busschbach
- University of Groningen, University Medical Center Groningen, University Center of Psychiatry, Rob Giel Onderzoekcentrum, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands
- Department of Movement and Education, Windesheim University of Applied Sciences, Campus 2-6, 8017 CA, Zwolle, The Netherlands
| |
Collapse
|
8
|
Setiadi TM, Opmeer EM, Martens S, Marsman JC, Tumati S, Reesink FE, De Deyn PP, Aleman A, Ćurčić‐Blake B. Apathy and white matter integrity in amnestic mild cognitive impairment: A whole brain analysis with tract‐based spatial statistics. Alzheimers Dement 2020. [DOI: 10.1002/alz.040838] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Tania M Setiadi
- University of Groningen University Medical Center Groningen Groningen Netherlands
| | - Esther M Opmeer
- University of Groningen University Medical Center Groningen Groningen Netherlands
- Windesheim University of Applied Science Zwolle Netherlands
| | - Sander Martens
- University of Groningen University Medical Center Groningen Groningen Netherlands
| | | | - Shankar Tumati
- University of Groningen University Medical Center Groningen Groningen Netherlands
- Institute of Mental Health Research University of Ottawa Ottawa Canada
| | - Fransje E Reesink
- University of Groningen University Medical Center Groningen Groningen Netherlands
| | - Peter Paul De Deyn
- University of Groningen University Medical Center Groningen Groningen Netherlands
- Institute Born‐Bunge University of Antwerp Antwerp Belgium
| | - André Aleman
- University of Groningen University Medical Center Groningen Groningen Netherlands
| | | |
Collapse
|
9
|
Ai H, Opmeer EM, Marsman JBC, Veltman DJ, van der Wee NJA, Aleman A, van Tol MJ. Longitudinal brain changes in MDD during emotional encoding: effects of presence and persistence of symptomatology. Psychol Med 2020; 50:1316-1326. [PMID: 31169102 DOI: 10.1017/s0033291719001259] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
BACKGROUND The importance of the hippocampus and amygdala for disrupted emotional memory formation in depression is well-recognized, but it remains unclear whether functional abnormalities are state-dependent and whether they are affected by the persistence of depressive symptoms. METHODS Thirty-nine patients with major depressive disorder and 28 healthy controls were included from the longitudinal functional magnetic resonance imaging (fMRI) sub-study of the Netherlands Study of Depression and Anxiety. Participants performed an emotional word-encoding and -recognition task during fMRI at baseline and 2-year follow-up measurement. At baseline, all patients were in a depressed state. We investigated state-dependency by relating changes in brain activation over time to changes in symptom severity. Furthermore, the effect of time spent with depressive symptoms in the 2-year interval was investigated. RESULTS Symptom change was linearly associated with higher activation over time of the left anterior hippocampus extending to the amygdala during positive and negative word-encoding. Especially during positive word encoding, this effect was driven by symptomatic improvement. There was no effect of time spent with depression in the 2-year interval on change in brain activation. Results were independent of medication- and psychotherapy-use. CONCLUSION Using a longitudinal within-subjects design, we showed that hippocampal-amygdalar activation during emotional memory formation is related to depressive symptom severity but not persistence (i.e. time spent with depression or 'load'), suggesting functional activation patterns in depression are not subject to functional 'scarring' although this hypothesis awaits future replication.
Collapse
Affiliation(s)
- Hui Ai
- Shenzhen Key Laboratory of Affective and Social Neuroscience, Center for Brain Disorders and Cognitive Sciences, Shenzhen University, Shenzhen, China
- Cognitive Neuroscience Center, Department of Biomedical Sciences of Cells and Systems, University Medical Center Groningen, Groningen, The Netherlands
| | - Esther M Opmeer
- Cognitive Neuroscience Center, Department of Biomedical Sciences of Cells and Systems, University Medical Center Groningen, Groningen, The Netherlands
| | - Jan-Bernard C Marsman
- Cognitive Neuroscience Center, Department of Biomedical Sciences of Cells and Systems, University Medical Center Groningen, Groningen, The Netherlands
| | - Dick J Veltman
- Department of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
- Department of Anatomy and Neurosciences, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
| | - Nic J A van der Wee
- Department of Psychiatry, Leiden University Medical Center, Leiden, The Netherlands
- Leiden University, Leiden Institute for Brain and Cognition, Leiden, The Netherlands
| | - André Aleman
- Shenzhen Key Laboratory of Affective and Social Neuroscience, Center for Brain Disorders and Cognitive Sciences, Shenzhen University, Shenzhen, China
- Cognitive Neuroscience Center, Department of Biomedical Sciences of Cells and Systems, University Medical Center Groningen, Groningen, The Netherlands
| | - Marie-José van Tol
- Cognitive Neuroscience Center, Department of Biomedical Sciences of Cells and Systems, University Medical Center Groningen, Groningen, The Netherlands
| |
Collapse
|
10
|
Jutten RJ, Harrison JE, Brunner A, Vreeswijk R, van Deelen R, de Jong FJ, Opmeer EM, Ritchie CW, Aleman A, Scheltens P, Sikkes SA. The Cognitive-Functional Composite is sensitive to clinical progression in early dementia: Longitudinal findings from the Catch-Cog study cohort. Alzheimers Dement (N Y) 2020; 6:e12020. [PMID: 32313832 PMCID: PMC7164406 DOI: 10.1002/trc2.12020] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/13/2020] [Accepted: 03/06/2020] [Indexed: 12/18/2022]
Abstract
INTRODUCTION In an attempt to capture clinically meaningful cognitive decline in early dementia, we developed the Cognitive-Functional Composite (CFC). We investigated the CFC's sensitivity to decline in comparison to traditional clinical endpoints. METHODS This longitudinal construct validation study included 148 participants with subjective cognitive decline, mild cognitive impairment, or mild dementia. The CFC and traditional tests were administered at baseline, 3, 6, and 12 months. Sensitivity to change was investigated using linear mixed models and r 2 effect sizes. RESULTS CFC scores declined over time (β = -.16, P < .001), with steepest decline observed in mild Alzheimer's dementia (β = -.25, P < .001). The CFC showed medium-to-large effect sizes at succeeding follow-up points (r 2 = .08-.42), exhibiting greater change than the Clinical Dementia Rating scale (r 2 = .02-.12). Moreover, change on the CFC was significantly associated with informant reports of cognitive decline (β = .38, P < .001). DISCUSSION By showing sensitivity to decline, the CFC could enhance the monitoring of disease progression in dementia research and clinical practice.
Collapse
Affiliation(s)
- Roos J. Jutten
- Alzheimer Center AmsterdamDepartment of NeurologyAmsterdam Neuroscience, AmsterdamAmsterdam UMCthe Netherlands
| | - John E. Harrison
- Alzheimer Center AmsterdamDepartment of NeurologyAmsterdam Neuroscience, AmsterdamAmsterdam UMCthe Netherlands
- Metis Cognition LtdWiltshireUK
- Institute of PsychiatryPsychology & NeuroscienceKing's College LondonLondonUK
| | - A.J. Brunner
- Alzheimer Center AmsterdamDepartment of NeurologyAmsterdam Neuroscience, AmsterdamAmsterdam UMCthe Netherlands
| | - R. Vreeswijk
- Department of GeriatricsSpaarne GasthuisHaarlemthe Netherlands
| | | | - Frank Jan de Jong
- Department of NeurologyErasmus Medical CenterRotterdamthe Netherlands
| | - Esther M. Opmeer
- Department of NeurosciencesUniversity of GroningenUniversity Medical Center GroningenGroningenthe Netherlands
- Department of Health and Social WorkUniversity of Applied Sciences WindesheimZwollethe Netherlands
| | - Craig W. Ritchie
- Centre for Dementia PreventionUniversity of EdinburghEdinburghUK
| | - André Aleman
- Department of NeurosciencesUniversity of GroningenUniversity Medical Center GroningenGroningenthe Netherlands
| | - Philip Scheltens
- Alzheimer Center AmsterdamDepartment of NeurologyAmsterdam Neuroscience, AmsterdamAmsterdam UMCthe Netherlands
| | - Sietske A.M. Sikkes
- Alzheimer Center AmsterdamDepartment of NeurologyAmsterdam Neuroscience, AmsterdamAmsterdam UMCthe Netherlands
- Department of Clinical, Neuro‐ & Developmental PsychologyVrije Universiteit AmsterdamAmsterdamthe Netherlands
| |
Collapse
|
11
|
Zhang L, Ai H, Opmeer EM, Marsman JBC, van der Meer L, Ruhé HG, Aleman A, van Tol MJ. Distinct temporal brain dynamics in bipolar disorder and schizophrenia during emotion regulation. Psychol Med 2020; 50:413-421. [PMID: 30773147 PMCID: PMC7025159 DOI: 10.1017/s0033291719000217] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/28/2017] [Revised: 10/16/2018] [Accepted: 01/18/2019] [Indexed: 12/17/2022]
Abstract
BACKGROUND Disturbances in emotion regulation (ER) are characteristic of both patients with bipolar disorder (BD) and schizophrenia (SZ). We investigated the temporal dynamics of brain activation during cognitive ER in BD and SZ to understand the contribution of temporal characteristics of disturbed ER to their unique and shared symptomatology. METHOD Forty-six participants performed an ER-task (BD, n = 15; SZ, n = 16; controls, n = 15) during functional magnetic resonance imaging, in which they were instructed to use cognitive reappraisal techniques to regulate their emotional responses. Finite impulse response modeling was applied to estimate the temporal dynamics of brain responses during cognitive reappraisal (v. passive attending) of negative pictures. Group, time, and group × time effects were tested using multivariate modeling. RESULTS We observed a group × time interaction during ER in the ventrolateral prefrontal cortex (VLPFC), supplementary motor area (SMA) and inferior occipital gyrus. Patients with SZ demonstrated initial hyper-activation of the VLPFC and SMA activation that was not sustained in later regulatory phases. Response profiles in the inferior occipital gyrus in SZ showed abnormal activation in the later phases of regulation. BD-patients showed general blunted responsivity in these regions. CONCLUSIONS These results suggest that ER-disturbances in SZ are characterized by an inefficient initialization and failure to sustain regulatory control, whereas in BD, a failure to recruit regulatory resources may represent initial deficits in formulating adequate representations of the regulatory needs. This may help to further understand how ER-disturbances give rise to symptomatology of BD and SZ.
Collapse
Affiliation(s)
- Liwen Zhang
- Department of Pharmacology, National University of Singapore, Singapore
| | - Hui Ai
- Shenzhen Key Laboratory of Affective and Social Neuroscience, Shenzhen University, Shenzhen, China
| | - Esther M. Opmeer
- University of Groningen, University Medical Center Groningen, Cognitive Neuroscience Center, Groningen, the Netherlands
| | - Jan-Bernard C. Marsman
- University of Groningen, University Medical Center Groningen, Cognitive Neuroscience Center, Groningen, the Netherlands
| | - Lisette van der Meer
- Department of Rehabilitation, Lentis Psychiatric Institute, Zuidlaren, the Netherlands
| | - Henricus G. Ruhé
- Department of Psychiatry, Radboud University Medical Center, Nijmegen, Netherlands
| | - André Aleman
- University of Groningen, University Medical Center Groningen, Cognitive Neuroscience Center, Groningen, the Netherlands
- Department of Psychology, University of Groningen, Groningen, the Netherlands
| | - Marie-José van Tol
- University of Groningen, University Medical Center Groningen, Cognitive Neuroscience Center, Groningen, the Netherlands
| |
Collapse
|
12
|
Geugies H, Opmeer EM, Marsman JBC, Figueroa CA, van Tol MJ, Schmaal L, van der Wee NJA, Aleman A, Penninx BWJH, Veltman DJ, Schoevers RA, Ruhé HG. Decreased functional connectivity of the insula within the salience network as an indicator for prospective insufficient response to antidepressants. Neuroimage Clin 2019; 24:102064. [PMID: 31795046 PMCID: PMC6883326 DOI: 10.1016/j.nicl.2019.102064] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/31/2018] [Revised: 10/01/2019] [Accepted: 11/03/2019] [Indexed: 01/04/2023]
Abstract
Connectivity analyses complemented with a metric exploring switching in brain activity. Lower insula-salience connectivity predicts insufficient antidepressant response. This same insula region is activated less when switching from task to a rest. This could be a potential biomarkers for predicting future antidepressant response.
Insufficient response to treatment is the main cause of prolonged suffering from major depressive disorder (MDD). Early identification of insufficient response could result in faster and more targeted treatment strategies to reduce suffering. We therefore explored whether baseline alterations within and between resting state functional connectivity networks could serve as markers of insufficient response to antidepressant treatment in two years of follow-up. We selected MDD patients (N = 17) from the NEtherlands Study of Depression and Anxiety (NESDA), who received ≥ two antidepressants, indicative for insufficient response, during the two year follow-up, a group of MDD patients who received only one antidepressant (N = 32) and a healthy control group (N = 19) matched on clinical characteristics and demographics. An independent component analysis (ICA) of baseline resting-state scans was conducted after which functional connectivity within the components was compared between groups. We observed lower connectivity of the right insula within the salience network in the group with ≥ two antidepressants compared to the group with one antidepressant. No difference in connectivity was found between the patient groups and healthy control group. Given the suggested role of the right insula in switching between task-positive mode (activation during attention-demanding tasks) and task-negative mode (activation during the absence of any task), we explored whether right insula activation differed during switching between these two modes. We observed that in the ≥2 antidepressant group, the right insula was less active compared to the group with one antidepressant, when switching from task-positive to task-negative mode than the other way around. These findings imply that lower right insula connectivity within the salience network may serve as an indicator for prospective insufficient response to antidepressants. This result, supplemented by the diminished insula activation when switching between task and rest related networks, could indicate an underlying mechanism that, if not sufficiently targeted by current antidepressants, could lead to insufficient response. When replicated, these findings may contribute to the identification of biomarkers for early detection of insufficient response.
Collapse
Affiliation(s)
- H Geugies
- University Medical Center Groningen, University Center for Psychiatry, Mood and Anxiety Disorders, University of Groningen, Groningen, the Netherlands; University Medical Center Groningen, Department of Neuroscience, Cognitive Neuroscience Center, University of Groningen, Groningen, the Netherlands.
| | - E M Opmeer
- University Medical Center Groningen, Department of Neuroscience, Cognitive Neuroscience Center, University of Groningen, Groningen, the Netherlands
| | - J B C Marsman
- University Medical Center Groningen, Department of Neuroscience, Cognitive Neuroscience Center, University of Groningen, Groningen, the Netherlands
| | - C A Figueroa
- Department of Psychiatry, Amsterdam UMC, Locatie AMC, University of Amsterdam, Amsterdam, the Netherlands
| | - M J van Tol
- University Medical Center Groningen, Department of Neuroscience, Cognitive Neuroscience Center, University of Groningen, Groningen, the Netherlands
| | - L Schmaal
- Department of Psychiatry, Amsterdam UMC, Locatie VUmc, VU University Amsterdam, Amsterdam, the Netherlands; Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, Australia; Centre for Youth Mental Health, The University of Melbourne, Melbourne, Australia
| | - N J A van der Wee
- Department of Psychiatry, Leiden University Medical Center, Leiden, the Netherlands; Leiden Institute for Brain and Cognition, Leiden University, Leiden, the Netherlands
| | - A Aleman
- University Medical Center Groningen, Department of Neuroscience, Cognitive Neuroscience Center, University of Groningen, Groningen, the Netherlands; Department of Psychology, University of Groningen, Groningen, the Netherlands
| | - B W J H Penninx
- Department of Psychiatry, Amsterdam UMC, Locatie VUmc, VU University Amsterdam, Amsterdam, the Netherlands
| | - D J Veltman
- Department of Psychiatry, Amsterdam UMC, Locatie VUmc, VU University Amsterdam, Amsterdam, the Netherlands
| | - R A Schoevers
- University Medical Center Groningen, University Center for Psychiatry, Mood and Anxiety Disorders, University of Groningen, Groningen, the Netherlands; Interdisciplinary Center Psychopathology and Emotion regulation (ICPE), University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; University of Groningen, Research School of Behavioural and Cognitive Neurosciences (BCN), Groningen, the Netherlands
| | - H G Ruhé
- University Medical Center Groningen, University Center for Psychiatry, Mood and Anxiety Disorders, University of Groningen, Groningen, the Netherlands; Department of Psychiatry, Amsterdam UMC, Locatie AMC, University of Amsterdam, Amsterdam, the Netherlands; Department of Psychiatry, Radboud University Medical Center, Nijmegen, the Netherlands.
| |
Collapse
|
13
|
Jutten RJ, Harrison J, Vreeswijk R, van Deelen BA, Opmeer EM, Aleman A, Jan de Jong F, Ritchie CW, Scheltens P, Sikkes SA. P3-028: THE COGNITIVE-FUNCTIONAL COMPOSITE IS SENSITIVE TO DISEASE PROGRESSION IN MILD COGNITIVE IMPAIRMENT AND EARLY DEMENTIA: LONGITUDINAL FINDINGS FROM THE CATCH-COG STUDY COHORT. Alzheimers Dement 2019. [DOI: 10.1016/j.jalz.2019.06.3054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Roos J. Jutten
- Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience; Vrije Universiteit Amsterdam, Amsterdam UMC; Amsterdam Netherlands
| | - John Harrison
- King's College - Institute of Psychiatry, Psychology and Neuroscience; London United Kingdom
- Metis Cognition Ltd.; Kilmington United Kingdom
- Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC; Vrije Universiteit Amsterdam; Amsterdam Netherlands
| | | | | | | | - André Aleman
- University Medical Center Groningen; Groningen Netherlands
| | - Frank Jan de Jong
- Department of Neurology and Alzheimer Center Erasmus MC; Erasmus Medical Center; Rotterdam Netherlands
| | | | - Philip Scheltens
- Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience; Vrije Universiteit Amsterdam, Amsterdam UMC; Amsterdam Netherlands
| | - Sietske A.M. Sikkes
- Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience; Vrije Universiteit Amsterdam, Amsterdam UMC; Amsterdam Netherlands
| |
Collapse
|
14
|
Xu P, Klaasen NG, Opmeer EM, Pijnenborg GHM, van Tol MJ, Liemburg EJ, Aleman A. Intrinsic mesocorticolimbic connectivity is negatively associated with social amotivation in people with schizophrenia. Schizophr Res 2019; 208:353-359. [PMID: 30711314 DOI: 10.1016/j.schres.2019.01.023] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/17/2018] [Revised: 01/15/2019] [Accepted: 01/20/2019] [Indexed: 01/26/2023]
Abstract
BACKGROUND Social amotivation is a core element of the negative symptoms of schizophrenia. However, it is still largely unknown which neural substrates underpin social amotivation in people with schizophrenia, though deficiencies in the mesocorticolimbic dopamine system have been proposed. METHODS We examined the association between social amotivation and substantia nigra/ventral tegmental area-seeded intrinsic connectivity in 84 people with schizophrenia using resting state functional magnetic resonance imaging. RESULTS Spontaneous fluctuations of midbrain dopaminergic regions were positively associated with striatal and prefrontal fluctuations in people with schizophrenia. Most importantly, social amotivation was negatively associated with functional connectivity between the midbrain's substantia nigra/ventral tegmental area and medial- and lateral prefrontal cortex, the temporoparietal junction, and dorsal and ventral striatum. These associations were observed independently of depressive and positive symptoms. CONCLUSIONS Our findings suggest that social amotivation in people with schizophrenia is associated with altered intrinsic connectivity of mesocorticolimbic pathways linked to cognitive control and reward processing. Dysconnectivity of dopaminergic neuronal ensembles that are fundamental to approach behavior and motivation may help explain the lack of initiative social behavior in people with social amotivation.
Collapse
Affiliation(s)
- Pengfei Xu
- Shenzhen Key Laboratory of Affective and Social Neuroscience, Center for Brain Disorders and Cognitive Sciences, Shenzhen University, Shenzhen, China; Center for Neuroimaging, Shenzhen Institute of Neuroscience, Shenzhen, China; Cognitive Neuroscience Center, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
| | - Nicky G Klaasen
- Cognitive Neuroscience Center, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
| | - Esther M Opmeer
- Cognitive Neuroscience Center, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Health and Social Work, University of applied sciences Windesheim, Zwolle, the Netherlands
| | - Gerdina H M Pijnenborg
- Department of Psychology, University of Groningen, the Netherlands; Department of Psychotic Disorders, GGZ Drenthe, Assen, the Netherlands
| | - Marie-José van Tol
- Cognitive Neuroscience Center, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
| | - Edith J Liemburg
- Cognitive Neuroscience Center, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
| | - André Aleman
- Shenzhen Key Laboratory of Affective and Social Neuroscience, Center for Brain Disorders and Cognitive Sciences, Shenzhen University, Shenzhen, China; Cognitive Neuroscience Center, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Psychology, University of Groningen, the Netherlands
| |
Collapse
|
15
|
Jutten RJ, Harrison JE, Lee Meeuw Kjoe PR, Ingala S, Vreeswijk R, van Deelen RAJ, de Jong FJ, Opmeer EM, Aleman A, Ritchie CW, Scheltens P, Sikkes SAM. Assessing cognition and daily function in early dementia using the cognitive-functional composite: findings from the Catch-Cog study cohort. Alzheimers Res Ther 2019; 11:45. [PMID: 31092277 PMCID: PMC6521452 DOI: 10.1186/s13195-019-0500-5] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/29/2019] [Accepted: 04/28/2019] [Indexed: 12/15/2022]
Abstract
Background The cognitive-functional composite (CFC) was designed to improve the measurement of clinically relevant changes in predementia and early dementia stages. We have previously demonstrated its good test-retest reliability and feasibility of use. The current study aimed to evaluate several quality aspects of the CFC, including construct validity, clinical relevance, and suitability for the target population. Methods Baseline data of the Capturing Changes in Cognition study was used: an international, prospective cohort study including participants with subjective cognitive decline (SCD), mild cognitive impairment (MCI), Alzheimer’s disease (AD) dementia, and dementia with Lewy bodies (DLB). The CFC comprises seven existing cognitive tests focusing on memory and executive functions (EF) and the informant-based Amsterdam Instrumental Activities of Daily Living Questionnaire (A-IADL-Q). Construct validity and clinical relevance were assessed by (1) confirmatory factor analyses (CFA) using all CFC subtests and (2) linear regression analyses relating the CFC score (independent) to reference measures of disease severity (dependent), correcting for age, sex, and education. To assess the suitability for the target population, we compared score distributions of the CFC to those of traditional tests (Alzheimer’s Disease Assessment Scale–Cognitive subscale, Alzheimer’s Disease Cooperative Study–Activities of Daily Living scale, and Clinical Dementia Rating scale). Results A total of 184 participants were included (age 71.8 ± 8.4; 42% female; n = 14 SCD, n = 80 MCI, n = 78 AD, and n = 12 DLB). CFA showed that the hypothesized three-factor model (memory, EF, and IADL) had adequate fit (CFI = .931, RMSEA = .091, SRMR = .06). Moreover, worse CFC performance was associated with more cognitive decline as reported by the informant (β = .61, p < .001), poorer quality of life (β = .51, p < .001), higher caregiver burden (β = − .51, p < .001), more apathy (β = − .36, p < .001), and less cortical volume (β = .34, p = .02). Whilst correlations between the CFC and traditional measures were moderate to strong (ranging from − .65 to .83, all p < .001), histograms showed floor and ceiling effects for the traditional tests as compared to the CFC. Conclusions Our findings illustrate that the CFC has good construct validity, captures clinically relevant aspects of disease severity, and shows no range restrictions in scoring. It therefore provides a more useful outcome measure than traditional tests to evaluate cognition and function in MCI and mild AD. Electronic supplementary material The online version of this article (10.1186/s13195-019-0500-5) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- Roos J Jutten
- Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
| | - John E Harrison
- Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.,Metis Cognition Ltd, Park House, Kilmington Common, Wiltshire, UK.,Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK
| | - Philippe R Lee Meeuw Kjoe
- Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
| | - Silvia Ingala
- Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.,Department of Radiology and Nuclear Medicine Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
| | - R Vreeswijk
- Department of Geriatrics, Spaarne Gasthuis, Haarlem, The Netherlands
| | - R A J van Deelen
- Department of Geriatrics, Spaarne Gasthuis, Haarlem, The Netherlands
| | - Frank Jan de Jong
- Department of Neurology, Erasmus Medical Center, Rotterdam, The Netherlands
| | - Esther M Opmeer
- Department of Biomedical Sciences, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.,Department of Health and Social Work, University of Applied Sciences Windesheim, Zwolle, The Netherlands
| | - André Aleman
- Department of Biomedical Sciences, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
| | - Craig W Ritchie
- Centre for Dementia Prevention, University of Edinburgh, Edinburgh, UK
| | - Philip Scheltens
- Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
| | - Sietske A M Sikkes
- Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.,Department of Epidemiology & Biostatistics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
| |
Collapse
|
16
|
Ai H, van Tol MJ, Marsman JBC, Veltman DJ, Ruhé HG, van der Wee NJA, Opmeer EM, Aleman A. Differential relations of suicidality in depression to brain activation during emotional and executive processing. J Psychiatr Res 2018; 105:78-85. [PMID: 30212727 DOI: 10.1016/j.jpsychires.2018.08.018] [Citation(s) in RCA: 20] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/06/2018] [Revised: 07/02/2018] [Accepted: 08/13/2018] [Indexed: 10/28/2022]
Abstract
Suicidal behavior is highly prevalent in major depressive disorder (MDD), though not present in all patients. It is unclear whether the tendency for suicidal behavior is associated with a unique functional neuroanatomical signature identifiable through neuroimaging. In this study, we investigated brain activation in suicidal and non-suicidal patients with MDD during facial emotion processing and executive control. Functional magnetic resonance imaging (fMRI) data from the NESDA-fMRI study (MDD patients N = 103, healthy controls N = 26, HC) were analyzed. Patients were divided in a group of suicide attempters (N = 18, SA), suicide ideators (N = 31, SI) and a patient-control group (N = 73, PC). A gender discrimination task with emotional faces and the Tower of London executive planning task were investigated. An ANOVA was performed to compare brain activation among suicidal patients (SA + SI), PC and HC first and then among SI, SA, PC and HC. Significance was determined as meeting p < .05 family wise error (FWE) corrected at the voxel-level. We observed that SA patients showed lower activation in the bilateral fusiform gyri during emotional faces processing compared to SI, PC and HC. No group differences were found during executive planning. Results were independent of childhood emotional maltreatment, depression severity, anxiety severity, use of psychotherapy and SSRI-use. Results suggest that a propensity for suicidal behavior in MDD is associated with abnormal emotional processing but not executive functioning, represented by altered face processing compared to non-suicidal patients and controls. While in need of replication, these results indicate that altered fusiform gyrus activation during emotion processing may serve as a marker for suicidality.
Collapse
Affiliation(s)
- Hui Ai
- College of Psychology and Sociology, Shenzhen University, PR China; University of Groningen, University Medical Center Groningen, Department of Neuroscience, Groningen, the Netherlands.
| | - Marie-José van Tol
- University of Groningen, University Medical Center Groningen, Department of Neuroscience, Groningen, the Netherlands
| | - Jan-Bernard C Marsman
- University of Groningen, University Medical Center Groningen, Department of Neuroscience, Groningen, the Netherlands
| | - Dick J Veltman
- VU University Medical Center Amsterdam, Department of Psychiatry, the Netherlands; VU University, Amsterdam Neuroscience, Amsterdam, the Netherlands
| | - Henricus G Ruhé
- University of Groningen, University Medical Center Groningen, Department of Psychiatry, Groningen, the Netherlands; University of Amsterdam, Academic Medical Center, Department of Psychiatry, Amsterdam, the Netherlands
| | - Nic J A van der Wee
- Leiden University Medical Center, Department of Psychiatry, the Netherlands; Leiden University, Leiden Institute for Brain and Cognition, Leiden, the Netherlands
| | - Esther M Opmeer
- University of Groningen, University Medical Center Groningen, Department of Neuroscience, Groningen, the Netherlands
| | - André Aleman
- College of Psychology and Sociology, Shenzhen University, PR China; University of Groningen, University Medical Center Groningen, Department of Neuroscience, Groningen, the Netherlands; University of Groningen, Department of Psychology, the Netherlands.
| |
Collapse
|
17
|
Jutten RJ, Harrison J, Opmeer EM, Aleman A, Vreeswijk R, Deelen BA, Jan de Jong F, Ritchie CW, Scheltens P, Sikkes SA. P4‐113: COMPARING THE COGNITIVE‐FUNCTIONAL COMPOSITE WITH TRADITIONAL TESTS OF COGNITION AND FUNCTION: FINDINGS FROM THE CATCH‐COG STUDY COHORT. Alzheimers Dement 2018. [DOI: 10.1016/j.jalz.2018.06.2517] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Affiliation(s)
- Roos J. Jutten
- Alzheimer Center and Department of Neurology, Amsterdam NeuroscienceVU University Medical CenterAmsterdamNetherlands
| | - John Harrison
- Alzheimer CenterVU University Medical CenterAmsterdamNetherlands
- King's College-Institute of PsychiatryPsychology and NeuroscienceLondonUnited Kingdom
- Metis Cognition Ltd.KilmingtonUnited Kingdom
| | | | - André Aleman
- University Medical Center GroningenGroningenNetherlands
| | | | | | - Frank Jan de Jong
- Department of Neurology and Alzheimer Center Erasmus MCErasmus Medical CenterRotterdamNetherlands
| | | | - Philip Scheltens
- VU University Medical CenterAlzheimer Center, Amsterdam NeuroscienceAmsterdamNetherlands
| | - Sietske A.M. Sikkes
- VU University Medical CenterAlzheimer Center, Amsterdam NeuroscienceAmsterdamNetherlands
- Department of Epidemiology and BiostatisticsVU University Medical CenterAmsterdamNetherlands
| |
Collapse
|
18
|
Vloeberghs R, Opmeer EM, De Deyn PP, Engelborghs S, De Roeck EE. [Apathy, depression and cognitive functioning in patients with MCI and dementia]. Tijdschr Gerontol Geriatr 2018; 49:95-102. [PMID: 29488192 DOI: 10.1007/s12439-018-0248-6] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/16/2017] [Accepted: 02/01/2018] [Indexed: 06/08/2023]
Abstract
BACKGROUND In dementia, apathy and depression are often seen as one disorder because of the many overlapping symptoms. However, for therapy a correct differentiation is essential. Moreover, apathy and depression are likely both associated with different cognitive deficits and progression of the disease. In this research we give an overview of cognitive domains associated with apathy and depression in MCI patients and report how often both disorders occur in a population sample. METHOD We administered the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) to 117 cognitively healthy controls (GC), 97 patients with mild cognitive impairment (MCI) and 50 patients with dementia (DEM). In addition, the Apathy Evaluation Scale clinical version (AES-C) and the Geriatric Depression Scale (GDS) were administered. RESULTS The number of patients with apathy increased with cognitive decline with respectively 3.4%, 10.4% and 41.5% of patients in the GC, MCI and DEM group. The prevalence of isolated depression was highest in the MCI group (18.8%). Correlation analyses in the MCI group showed that apathy and not depression was associated with a deficit in encoding, attention and global cognitive functioning. CONCLUSION The prevalence of apathy and depressive symptoms is different in patients with MCI, DEM and GC, and within the MCI group apathy and depression are associated with different cognitive domains.
Collapse
Affiliation(s)
- Robin Vloeberghs
- Thomas More Hogeschool, Antwerpen, België
- Referentiecentrum voor Biologische Markers van Dementie, Universiteit Antwerpen, Antwerpen, België
| | - Esther M Opmeer
- Universitair Medisch Centrum Groningen, Afdeling Neurowetenschappen, Rijksuniversiteit Groningen, Groningen, Nederland
| | - Peter P De Deyn
- Referentiecentrum voor Biologische Markers van Dementie, Universiteit Antwerpen, Antwerpen, België
- Departement Neurologie en Geheugenkliniek, ZNA Middelheim en Hoge Beuken, Antwerpen, België
- Universitair Medisch Centrum Groningen, Afdeling Neurologie en Alzheimer Research Centrum, Rijksuniversiteit Groningen, Groningen, Nederland
| | - Sebastiaan Engelborghs
- Referentiecentrum voor Biologische Markers van Dementie, Universiteit Antwerpen, Antwerpen, België
- Departement Neurologie en Geheugenkliniek, ZNA Middelheim en Hoge Beuken, Antwerpen, België
| | - Ellen E De Roeck
- Referentiecentrum voor Biologische Markers van Dementie, Universiteit Antwerpen, Antwerpen, België.
- Departement psychologie en educatiewetenschappen, Vrije Universiteit Brussel, Brussel, België.
- Departement Biomedische Wetenschappen, Campus Drie Eiken, Universiteit Antwerpen, Wilrijk, België.
| |
Collapse
|
19
|
Zhang L, Opmeer EM, van der Meer L, Aleman A, Ćurčić-Blake B, Ruhé HG. Altered frontal-amygdala effective connectivity during effortful emotion regulation in bipolar disorder. Bipolar Disord 2018; 20:349-358. [PMID: 29430790 DOI: 10.1111/bdi.12611] [Citation(s) in RCA: 26] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/08/2016] [Accepted: 12/15/2017] [Indexed: 01/07/2023]
Abstract
OBJECTIVES Sufficient prefrontal top-down control of limbic affective areas, especially the amygdala, is essential for successful effortful emotion regulation (ER). Difficulties in effortful ER have been seen in patients with bipolar disorder (BD), which could be suggestive of a disturbed prefrontal-amygdala regulation circuit. The aim of this study was to investigate whether BD patients show abnormal effective connectivity from the prefrontal areas to the amygdala during effortful ER (reappraisal). METHODS Forty participants (23 BD patients and 17 healthy controls [HC]) performed an ER task during functional magnetic resonance imaging. Using dynamic causal modeling, we investigated effective connectivity from the dorsolateral prefrontal cortex (DLPFC) and ventrolateral prefrontal cortex (VLPFC) to the amygdala, as well as connectivity between the DLPFC and VLPFC during reappraisal. RESULTS Both BD patients and HC showed decreased negative affect ratings following reappraisal compared to attending negative pictures (P < .001). There were no group differences (P = .10). There was a differential modulatory effect of reappraisal on the connectivity from the DLPFC to amygdala between BD patients and HC (P = .04), with BD patients showing a weaker modulatory effect on this connectivity compared to HC. There were no other group differences. CONCLUSION The disturbance in BD patients in effective connectivity from the DLPFC to the amygdala while reappraising is indicative of insufficient prefrontal control. This impairment should be studied further in relation to cycling frequency and polarity of switches in BD patients.
Collapse
Affiliation(s)
- Liwen Zhang
- Department of Neuroscience, NeuroImaging Center, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
| | - Esther M Opmeer
- Department of Neuroscience, NeuroImaging Center, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
| | - Lisette van der Meer
- Department of Neuroscience, NeuroImaging Center, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.,Department of Rehabilitation, Lentis Psychiatric Institute, Zuidlaren, , The Netherlands.,Rob Giel Research Center, University of Groningen, Groningen, The Netherlands
| | - André Aleman
- Department of Neuroscience, NeuroImaging Center, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.,Department of Psychology, University of Groningen, Groningen, The Netherlands
| | - Branislava Ćurčić-Blake
- Department of Neuroscience, NeuroImaging Center, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
| | - Henricus G Ruhé
- Department of Psychiatry, Mood and Anxiety Disorders, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
| |
Collapse
|
20
|
Tumati S, Opmeer EM, Marsman JBC, Martens S, Reesink FE, De Deyn PP, Aleman A. Lower Choline and Myo-Inositol in Temporo-Parietal Cortex Is Associated With Apathy in Amnestic MCI. Front Aging Neurosci 2018; 10:106. [PMID: 29706886 PMCID: PMC5909116 DOI: 10.3389/fnagi.2018.00106] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2017] [Accepted: 03/29/2018] [Indexed: 12/14/2022] Open
Abstract
Apathy is a common symptom in patients with amnestic mild cognitive impairment (aMCI) and is associated with an increased risk of progression to Alzheimer's disease (AD). The neural substrates underlying apathy in aMCI may involve multiple brain regions, including the anterior cingulate cortex and the temporo-parietal region. Here we investigated neurometabolites in brain regions that may underlie apathy in aMCI patients using proton magnetic resonance spectroscopy (1H-MRS). Twenty-eight aMCI patients with varying degrees of apathy and 20 matched controls underwent 1H-MRS. Spectra were acquired from single voxels in the posterior cingulate cortex (PCC), dorsal anterior cingulate cortex (DACC), right dorsolateral prefrontal cortex (DLPFC), and right temporo-parietal cortex (TPC). Apathy was measured with the Apathy Evaluation Scale (AES). Spearman partial correlations between metabolite concentrations in each region and severity of apathy were determined. Additionally, analyses of covariance (ANCOVA) were performed to determine whether metabolite changes differed between patients with or without clinically-diagnosed apathy. The degree of apathy was found to be negatively correlated with choline and myo-inositol (mI) in the TPC. Additional exploratory analyses suggested that N-acetylaspartate (NAA)/mI ratio was reduced in aMCI without clinical apathy but not in aMCI with clinical apathy. In the DACC, glutamate and glutamine (Glx) levels tended to be higher in the aMCI with apathy group compared to controls and reduced in association with depression scores. In conclusion, apathy in aMCI patients was associated with neurometabolite changes indicative of altered membranal integrity and glial function in the right TPC. Findings also indicated that in a clinically-diagnosed aMCI cohort, apathy symptoms may be suggestive of neural changes that are distinct from aMCI without apathy.
Collapse
Affiliation(s)
- Shankar Tumati
- Department of Neuroscience, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.,Mind, Brain Imaging and Neuroethics Research Unit, Institute of Mental Health Research, University of Ottawa; Royal Ottawa Mental Health Centre, Ottawa, ON, Canada
| | - Esther M Opmeer
- Department of Neuroscience, University of Groningen, University Medical Center Groningen, Groningen, Netherlands
| | - Jan-Bernard C Marsman
- Department of Neuroscience, University of Groningen, University Medical Center Groningen, Groningen, Netherlands
| | - Sander Martens
- Department of Neuroscience, University of Groningen, University Medical Center Groningen, Groningen, Netherlands
| | - Fransje E Reesink
- Department of Neurology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands
| | - Peter P De Deyn
- Department of Neurology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.,Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium
| | - André Aleman
- Department of Neuroscience, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.,Department of Psychology, University of Groningen, Groningen, Netherlands
| |
Collapse
|
21
|
Jutten RJ, Harrison J, Lee Meeuw Kjoe PR, Opmeer EM, Schoonenboom NSM, de Jong FJ, Ritchie CW, Scheltens P, Sikkes SAM. A novel cognitive-functional composite measure to detect changes in early Alzheimer's disease: Test-retest reliability and feasibility. Alzheimers Dement (Amst) 2017; 10:153-160. [PMID: 29780863 PMCID: PMC5956799 DOI: 10.1016/j.dadm.2017.12.002] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
Abstract
Introduction To improve the detection of changes in Alzheimer's disease (AD), we designed the cognitive-functional composite (CFC). As a first validation step, we investigated its test–retest reliability and feasibility of use. Methods We performed a test–retest study with 2–3 weeks between assessments, including patients with mild cognitive impairment (MCI) or mild AD dementia and cognitively healthy participants. We calculated intraclass correlation coefficients (ICCs) type absolute agreement for all CFC measures and compared baseline and retest scores using paired-samples t-tests. We evaluated feasibility by interviewing participants. Results Forty-three patients (40% female, mean age = 69.9) and 30 controls (50% female, mean age = 65) were included. Subtest intraclass correlation coefficients ranged from .70 to .96. We found negligible improvements after retesting on only two subtests. Overall, patients perceived the administration of the CFC as feasible. Discussion The CFC is a stable and feasible measure in MCI and mild AD dementia, and thereby meets important quality metrics for clinically meaningful outcome measures. We investigated stability and feasibility of the cognitive-functional composite (CFC). We demonstrated good test–retest reliability for all CFC subtests. We only found negligible practice effects on two CFC subtests. Overall, patients experienced the administration of the CFC as feasible.
Collapse
Affiliation(s)
- Roos J Jutten
- Alzheimer Center, Department of Neurology, VU University Medical Center, Amsterdam Neuroscience, Amsterdam, The Netherlands
| | - John Harrison
- Alzheimer Center, Department of Neurology, VU University Medical Center, Amsterdam Neuroscience, Amsterdam, The Netherlands.,Metis Cognition Ltd, Park House, Kilmington Common, Wiltshire, United Kingdom.,Institute of Psychiatry, Psychology & Neuroscience, King's College, London, United Kingdom
| | - Philippe R Lee Meeuw Kjoe
- Alzheimer Center, Department of Neurology, VU University Medical Center, Amsterdam Neuroscience, Amsterdam, The Netherlands
| | - Esther M Opmeer
- Department of Neurosciences, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
| | | | - Frank Jan de Jong
- Department of Neurology, Erasmus Medical Center, Rotterdam, The Netherlands
| | - Craig W Ritchie
- Centre for Dementia Prevention, University of Edinburgh, Edinburgh, United Kingdom
| | - Philip Scheltens
- Alzheimer Center, Department of Neurology, VU University Medical Center, Amsterdam Neuroscience, Amsterdam, The Netherlands
| | - Sietske A M Sikkes
- Alzheimer Center, Department of Neurology, VU University Medical Center, Amsterdam Neuroscience, Amsterdam, The Netherlands.,Department of Epidemiology & Biostatistics, VU University Medical Center, Amsterdam, The Netherlands
| |
Collapse
|
22
|
Klaasen NG, Kos C, Aleman A, Opmeer EM. Apathy is related to reduced activation in cognitive control regions during set-shifting. Hum Brain Mapp 2017; 38:2722-2733. [PMID: 28256779 DOI: 10.1002/hbm.23556] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2016] [Revised: 02/01/2017] [Accepted: 02/21/2017] [Indexed: 12/27/2022] Open
Abstract
Apathy is a prominent and influential symptom in several neurological and psychiatric disorders, but it also occurs in the healthy population. It has considerable impact on daily life functioning, in clinical as well as healthy samples. Even though cognitive control is thought to be disrupted in people with apathy, the exact neural underpinnings of apathy remain unclear. Because flexible shifting between behaviors (set-shifting) is crucial for goal-directed behavior, disruptions in set-shifting may underlie apathy. In this study, the neural correlates of apathy during set-shifting were studied in 34 healthy participants with varying levels of apathy, measured by the Apathy Evaluation Scale. During functional MRI scanning participants performed a set-shifting task, distinguishing between behavioral switches (a change in response to different stimuli), cognitive switches (a change in response rule), and salience decoupling (detecting a change in relevant stimuli). Regression analysis was used to assess the relationship between apathy and brain activation. Results showed that higher apathy scores were related to reduced activation in the medial superior frontal gyrus and cerebellum (Crus I/II) during cognitive set-shifting, but not behavioral shifting and salience decoupling. No relationship between apathy and accuracy or response time was found. These results support the idea that alterations in the neural basis of cognitive control, especially cognitive set-shifting, may contribute to apathy. Hum Brain Mapp 38:2722-2733, 2017. © 2017 Wiley Periodicals, Inc.
Collapse
Affiliation(s)
- Nicky G Klaasen
- Department of Neuroscience, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
| | - Claire Kos
- Department of Neuroscience, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
| | - André Aleman
- Department of Neuroscience, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.,Department of Psychology, University of Groningen, Groningen, The Netherlands
| | - Esther M Opmeer
- Department of Neuroscience, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
| |
Collapse
|
23
|
Zhang L, vander Meer L, Opmeer EM, Marsman JBC, Ruhé HG, Aleman A. Altered functional connectivity during self- and close other-reflection in patients with bipolar disorder with past psychosis and patients with schizophrenia. Neuropsychologia 2016; 93:97-105. [DOI: 10.1016/j.neuropsychologia.2016.09.020] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2016] [Revised: 09/13/2016] [Accepted: 09/26/2016] [Indexed: 01/14/2023]
|
24
|
van Velzen LS, Schmaal L, Jansen R, Milaneschi Y, Opmeer EM, Elzinga BM, van der Wee NJA, Veltman DJ, Penninx BWJH. Effect of childhood maltreatment and brain-derived neurotrophic factor on brain morphology. Soc Cogn Affect Neurosci 2016; 11:1841-1852. [PMID: 27405617 PMCID: PMC5091678 DOI: 10.1093/scan/nsw086] [Citation(s) in RCA: 41] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2015] [Revised: 06/01/2016] [Accepted: 06/20/2016] [Indexed: 01/09/2023] Open
Abstract
Childhood maltreatment (CM) has been associated with altered brain morphology, which may partly be due to a direct impact on neural growth, e.g. through the brain-derived neurotrophic factor (BDNF) pathway. Findings on CM, BDNF and brain volume are inconsistent and have never accounted for the entire BDNF pathway. We examined the effects of CM, BDNF (genotype, gene expression and protein level) and their interactions on hippocampus, amygdala and anterior cingulate cortex (ACC) morphology. Data were collected from patients with depression and/or an anxiety disorder and healthy subjects within the Netherlands Study of Depression and Anxiety (NESDA) (N = 289). CM was assessed using the Childhood Trauma Interview. BDNF Val66Met genotype, gene expression and serum protein levels were determined in blood and T1 MRI scans were acquired at 3T. Regional brain morphology was assessed using FreeSurfer. Covariate-adjusted linear regression analyses were performed. Amygdala volume was lower in maltreated individuals. This was more pronounced in maltreated met-allele carriers. The expected positive relationship between BDNF gene expression and volume of the amygdala is attenuated in maltreated subjects. Finally, decreased cortical thickness of the ACC was identified in maltreated subjects with the val/val genotype. CM was associated with altered brain morphology, partly in interaction with multiple levels of the BNDF pathway. Our results suggest that CM has different effects on brain morphology in met-carriers and val-homozygotes and that CM may disrupt the neuroprotective effect of BDNF.
Collapse
Affiliation(s)
- Laura S van Velzen
- Department of Psychiatry and Neuroscience Campus Amsterdam, VU University Medical Center and GGZ inGeest, Amsterdam, the Netherlands
| | - Lianne Schmaal
- Department of Psychiatry and Neuroscience Campus Amsterdam, VU University Medical Center and GGZ inGeest, Amsterdam, the Netherlands
| | - Rick Jansen
- Department of Psychiatry and Neuroscience Campus Amsterdam, VU University Medical Center and GGZ inGeest, Amsterdam, the Netherlands
| | - Yuri Milaneschi
- Department of Psychiatry and Neuroscience Campus Amsterdam, VU University Medical Center and GGZ inGeest, Amsterdam, the Netherlands
| | - Esther M Opmeer
- Department of Neuroscience, University of Groningen, NeuroImaging Center, University Medical Center Groningen, Groningen, the Netherlands
| | - Bernet M Elzinga
- Institute of Psychology and Leiden Institute for Brain and Cognition (LIBC), Leiden University, Leiden, the Netherlands
| | - Nic J A van der Wee
- Institute of Psychiatry and Leiden Institute for Brain and Cognition (LIBC), Leiden University, Leiden, the Netherlands
| | - Dick J Veltman
- Department of Psychiatry and Neuroscience Campus Amsterdam, VU University Medical Center and GGZ inGeest, Amsterdam, the Netherlands
| | - Brenda W J H Penninx
- Department of Psychiatry and Neuroscience Campus Amsterdam, VU University Medical Center and GGZ inGeest, Amsterdam, the Netherlands
- Department of Psychiatry and the EMGO+ Institute for Health and Care Research, VU University Medical Center, Amsterdam, the Netherlands
| |
Collapse
|
25
|
Opmeer EM, Kortekaas R, van Tol MJ, Renken RJ, Demenescu LR, Woudstra S, Ter Horst GJ, van Buchem MA, van der Wee NJA, Veltman DJ, Aleman A. CHANGES IN REGIONAL BRAIN ACTIVATION RELATED TO DEPRESSIVE STATE: A 2-YEAR LONGITUDINAL FUNCTIONAL MRI STUDY. Depress Anxiety 2016; 33:35-44. [PMID: 26378742 DOI: 10.1002/da.22425] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/23/2014] [Revised: 08/21/2015] [Accepted: 08/25/2015] [Indexed: 01/29/2023] Open
Abstract
BACKGROUND Abnormal brain activations during processing of emotional facial expressions in depressed patients have been demonstrated. We investigated the natural course of brain activation in response to emotional faces in depression, indexed by functional magnetic resonance imaging (fMRI) scans preceding and following change in depressive state. We hypothesized a decrease in activation in the amygdala, anterior cingulate cortex (ACC), and insula with a decrease in depressive pathology. METHODS A 2-year longitudinal fMRI study was conducted as part of the Netherlands Study of Depression and Anxiety. We included 32 healthy controls and 49 depressed patients. During the second scan, 27 patients were in remission (remitters), the other 22 were not (nonremitters). All participants viewed faces with emotional expressions during scanning. RESULTS Rostral ACC activation during processing of happy faces was predictive of a decrease in depressive state (PFWE = .003). In addition, remitters showed decreased activation of the insula over time (PFWE = .016), specifically during happy faces. Nonremitters displayed increased abnormalities in emotion recognition circuitry during the second scan compared to the first. No effect of selective serotonin reuptake inhibitor use was observed. CONCLUSIONS Our results demonstrate that rostral ACC activation may predict changes in depressive state even at 2-year outcome. The association between change in depressed state and change in insula activation provides further evidence for the role of the insula in a network maintaining emotional and motivational states.
Collapse
Affiliation(s)
- Esther M Opmeer
- BCN Neuroimaging Center, Department of Neuroscience, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
| | - Rudie Kortekaas
- BCN Neuroimaging Center, Department of Neuroscience, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
| | - Marie-José van Tol
- BCN Neuroimaging Center, Department of Neuroscience, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
| | - Remco J Renken
- BCN Neuroimaging Center, Department of Neuroscience, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
| | - Liliana R Demenescu
- Clinical Affective Neuroimaging Laboratory, Department of Neurology, Otto von Guericke University of Magdeburg, Magdeburg, Germany
| | - Saskia Woudstra
- Department of Psychiatry, Leiden University Medical Center, The Netherlands.,Department of Psychiatry, VU University Medical Center Amsterdam, The Netherlands.,Department of Medical Genomics, VU University Medical Center, Amsterdam, The Netherlands.,Neuroscience Campus Amsterdam, VU University, The Netherlands.,Leiden Institute for Brain and Cognition, Leiden University, Leiden, The Netherlands
| | - Gert J Ter Horst
- BCN Neuroimaging Center, Department of Neuroscience, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
| | - Mark A van Buchem
- Leiden Institute for Brain and Cognition, Leiden University, Leiden, The Netherlands.,Department of Radiology, Leiden University Medical Center, The Netherlands
| | - Nic J A van der Wee
- Department of Psychiatry, Leiden University Medical Center, The Netherlands.,Leiden Institute for Brain and Cognition, Leiden University, Leiden, The Netherlands
| | - Dick J Veltman
- Department of Psychiatry, VU University Medical Center Amsterdam, The Netherlands.,Neuroscience Campus Amsterdam, VU University, The Netherlands
| | - André Aleman
- BCN Neuroimaging Center, Department of Neuroscience, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.,Department of Psychology, University of Groningen, The Netherlands
| |
Collapse
|
26
|
van der Velde J, Opmeer EM, Liemburg EJ, Bruggeman R, Nieboer R, Wunderink L, Aleman A. Lower prefrontal activation during emotion regulation in subjects at ultrahigh risk for psychosis: an fMRI-study. NPJ Schizophr 2015; 1:15026. [PMID: 27336036 PMCID: PMC4849453 DOI: 10.1038/npjschz.2015.26] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/23/2014] [Revised: 04/04/2015] [Accepted: 06/04/2015] [Indexed: 11/09/2022]
Abstract
BACKGROUND Previous research has shown that patients with schizophrenia experience difficulties with emotion regulation and activate prefrontal regions to a lesser extent during reappraisal of emotional information. It has been suggested that problems in emotion regulation might precede the onset of psychosis. Therefore, it could be hypothesized that also individuals at ultrahigh risk (UHR) for developing psychosis experience difficulties with emotion regulation. AIMS The aim of the current study was to investigate whether individuals at UHR for developing psychosis show abnormal brain activation during reappraisal of negative pictures. METHODS Using functional magnetic resonance imaging (fMRI), we scanned 15 UHR participants and 16 matched healthy controls while performing an emotion regulation task. During this task, participants had to reappraise their negative emotion elicited by International Affective Picture System pictures. Furthermore, the reported use of reappraisal was examined with the emotion regulation questionnaire (ERQ). RESULTS Individuals at UHR for psychosis showed less activation in the left ventrolateral prefrontal cortex during reappraisal compared with healthy controls. Furthermore, they reported less use of reappraisal in daily life (P=0.01; 95% CI (0.24-1.63)). CONCLUSIONS These findings indicate that dysfunctional emotion regulation may already occur in individuals at risk for psychosis. These regulation difficulties are underpinned by less ventrolateral prefrontal cortex activation, and may result in high negative affect, lower social functioning, and high rates of psychotic symptoms.
Collapse
Affiliation(s)
- Jorien van der Velde
- Neuroimaging Center, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Academy for social studies, Hanze University of Applied Sciences, Groningen, The Netherlands
| | - Esther M Opmeer
- Neuroimaging Center, University of Groningen, University Medical Center Groningen , Groningen, The Netherlands
| | - Edith J Liemburg
- Neuroimaging Center, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Rob Giel Research Center, University Medical Center Groningen, Groningen, The Netherlands
| | - Richard Bruggeman
- Rob Giel Research Center, University Medical Center Groningen , Groningen, The Netherlands
| | - Roeline Nieboer
- Department of Psychosis studies, Mental Health Care Friesland , Leeuwarden, The Netherlands
| | - Lex Wunderink
- Department of Psychosis studies, Mental Health Care Friesland , Leeuwarden, The Netherlands
| | - André Aleman
- Neuroimaging Center, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Department of Psychology, University of Groningen, Groningen, The Netherlands
| |
Collapse
|
27
|
Ai H, Opmeer EM, Veltman DJ, van der Wee NJA, van Buchem MA, Aleman A, van Tol MJ. Brain Activation During Emotional Memory Processing Associated with Subsequent Course of Depression. Neuropsychopharmacology 2015; 40:2454-63. [PMID: 25857684 PMCID: PMC4538361 DOI: 10.1038/npp.2015.96] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/03/2014] [Revised: 02/10/2015] [Accepted: 04/01/2015] [Indexed: 12/28/2022]
Abstract
Major depressive disorder (MDD) is characterized by a heterogeneous course and identifying patients at risk for an unfavorable course is difficult. Neuroimaging studies may identify brain predictors of clinical course and may help to further unravel the neurobiological processes underlying an unfavorable course. We investigated whether brain activation during an emotional memory paradigm is associated with depressive course. To this end, we followed 74 MDD patients and 45 healthy controls (HCs) for 2 years. At baseline, participants performed an emotional word-encoding and -recognition task during functional magnetic resonance imaging. Activation patterns were compared between patients with fast remission (n=22), remission with recurrence (n=23), non-remission (n=29), and HCs. Additionally, linear relations of brain activation and time to remission during the follow-up period were investigated across patients. We observed that during encoding of negative words, non-remitters showed higher activation of the left insula than HCs. Groups also differed in activation of the right hippocampus and left amygdala during negative encoding, with a trend for higher activation in non-remitters compared with HCs. Furthermore, hippocampal activation during negative word encoding was significantly and positively correlated with time to remission, irrespective of illness severity. Our findings suggest that higher activation in the left insula could serve as a neural marker of a naturalistic non-remitting course, whereas higher hippocampal activation is associated with delayed remission. Longitudinal analyses should clarify whether abnormal activation progresses further as a function of time with depression or may serve as load-independent markers of MDD course.
Collapse
Affiliation(s)
- Hui Ai
- Department of Neuroscience, Neuroimaging Center, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands,Department of Neuroscience, Neuroimaging Center, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 2, Groningen 9713AW, The Netherlands, Tel: +31(0) 50 363 8792, Fax: +31(0)50 363 8875, E-mail:
| | - Esther M Opmeer
- Department of Neuroscience, Neuroimaging Center, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
| | - Dick J Veltman
- Department of Psychiatry, VU University Medical Center Amsterdam, Amsterdam, The Netherlands,Neuroscience Campus Amsterdam, VU University, Amsterdam, The Netherlands
| | - Nic J A van der Wee
- Department of Psychiatry, Leiden University Medical Center, Leiden, The Netherlands,Leiden Institute for Brain and Cognition, Leiden University, Leiden, The Netherlands
| | - Mark A van Buchem
- Leiden Institute for Brain and Cognition, Leiden University, Leiden, The Netherlands,Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands
| | - André Aleman
- Department of Neuroscience, Neuroimaging Center, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands,Department of Psychology, University of Groningen, Groningen, The Netherlands
| | - Marie-José van Tol
- Department of Neuroscience, Neuroimaging Center, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
| |
Collapse
|
28
|
Zhang L, Opmeer EM, Ruhé HG, Aleman A, van der Meer L. Brain activation during self- and other-reflection in bipolar disorder with a history of psychosis: Comparison to schizophrenia. Neuroimage Clin 2015; 8:202-9. [PMID: 26106544 PMCID: PMC4473805 DOI: 10.1016/j.nicl.2015.04.010] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/19/2014] [Revised: 04/14/2015] [Accepted: 04/16/2015] [Indexed: 01/03/2023]
Abstract
Objectives Reflecting on the self and on others activates specific brain areas and contributes to metacognition and social cognition. The aim of the current study is to investigate brain activation during self- and other-reflection in patients with bipolar disorder (BD). In addition, we examined whether potential abnormal brain activation in BD patients could distinguish BD from patients with schizophrenia (SZ). Methods During functional magnetic resonance imaging (fMRI), 17 BD patients, 17 SZ patients and 21 healthy controls (HCs) performed a self-reflection task. The task consisted of sentences divided into three conditions: self-reflection, other-reflection and semantic control. Results BD patients showed less activation in the posterior cingulate cortex (PCC) extending to the precuneus during other-reflection compared to HCs (p = 0.028 FWE corrected on cluster-level within the regions of interest). In SZ patients, the level of activation in this area was in between BD patients and HCs, with no significant differences between patients with SZ and BD. There were no group differences in brain activation during self-reflection. Moreover, there was a positive correlation between the PCC/precuneus activation during other-reflection and cognitive insight in SZ patients, but not in BD patients. Conclusions BD patients showed less activation in the PCC/precuneus during other-reflection. This may support an account of impaired integration of emotion and memory (evaluation of past and current other-related information) in BD patients. Correlation differences of the PCC/precuneus activation with the cognitive insight in patients with BD and SZ might reflect an important difference between these disorders, which may help to further explore potentially distinguishing markers. We investigated self-reflection and other-reflection in bipolar disorder. Bipolar had less PCC/precuneus activation during other-reflection than controls. PCC/precuneus activation was unrelated to cognitive insight in bipolar patients.
Collapse
Affiliation(s)
- Liwen Zhang
- Neuroimaging Center, Department of Neuroscience, University Medical Center, University of Groningen, Groningen, The Netherlands
| | - Esther M Opmeer
- Neuroimaging Center, Department of Neuroscience, University Medical Center, University of Groningen, Groningen, The Netherlands
| | - Henricus G Ruhé
- University Medical Center Groningen, Department of Psychiatry, University of Groningen, Program for Mood and Anxiety Disorders, Groningen, The Netherlands
| | - André Aleman
- Neuroimaging Center, Department of Neuroscience, University Medical Center, University of Groningen, Groningen, The Netherlands ; Department of Psychology, University of Groningen, Groningen, The Netherlands
| | - Lisette van der Meer
- Neuroimaging Center, Department of Neuroscience, University Medical Center, University of Groningen, Groningen, The Netherlands ; Department of Rehabilitation, Lentis Psychiatric Institute, Zuidlaren, The Netherlands
| |
Collapse
|
29
|
Opmeer EM, van Tol MJ, Kortekaas R, van der Wee NJA, Woudstra S, van Buchem MA, Penninx BW, Veltman DJ, Aleman A. DISC1 gene and affective psychopathology: a combined structural and functional MRI study. J Psychiatr Res 2015; 61:150-7. [PMID: 25533973 DOI: 10.1016/j.jpsychires.2014.11.014] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/13/2014] [Revised: 11/14/2014] [Accepted: 11/21/2014] [Indexed: 12/01/2022]
Abstract
The gene Disrupted-In-Schizophrenia-1 (DISC1) has been indicated as a determinant of psychopathology, including affective disorders, and shown to influence prefrontal cortex (PFC) and hippocampus functioning, regions of major interest for affective disorders. We aimed to investigate whether DISC1 differentially modulates brain function during executive and memory processing, and morphology in regions relevant for depression and anxiety disorders (affective disorders). 128 participants, with (n = 103) and without (controls; n = 25) affective disorders underwent genotyping for Ser704Cys (with Cys-allele considered as risk-allele) and structural and functional (f) Magnetic Resonance Imaging (MRI) during visuospatial planning and emotional episodic memory tasks. For both voxel-based morphometry and fMRI analyses, we investigated the effect of genotype in controls and explored genotypeXdiagnosis interactions. Results are reported at p < 0.05 FWE small volume corrected. In controls, Cys-carriers showed smaller bilateral (para)hippocampal volumes compared with Ser-homozygotes, and lower activation in the anterior cingulate cortex (ACC) and dorsolateral PFC during visuospatial planning. In anxiety patients, Cys-carriers showed larger (para)hippocampal volumes and more ACC activation during visuospatial planning. In depressive patients, no effect of genotype was observed and overall, no effect of genotype on episodic memory processing was detected. We demonstrated that Ser704Cys-genotype influences (para)hippocampal structure and functioning the dorsal PFC during executive planning, most prominently in unaffected controls. Results suggest that presence of psychopathology moderates Ser704Cys effects.
Collapse
Affiliation(s)
- Esther M Opmeer
- Neuroimaging Center, Department of Neuroscience, University Medical Center Groningen and University of Groningen, 9713 AW Groningen, The Netherlands.
| | - Marie-José van Tol
- Neuroimaging Center, Department of Neuroscience, University Medical Center Groningen and University of Groningen, 9713 AW Groningen, The Netherlands.
| | - Rudie Kortekaas
- Neuroimaging Center, Department of Neuroscience, University Medical Center Groningen and University of Groningen, 9713 AW Groningen, The Netherlands.
| | - Nic J A van der Wee
- Department of Psychiatry, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands; Leiden Institute for Brain and Cognition, Leiden University, 2300 RC Leiden, The Netherlands.
| | - Saskia Woudstra
- Department of Psychiatry, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands; Leiden Institute for Brain and Cognition, Leiden University, 2300 RC Leiden, The Netherlands; Department of Psychiatry, VU University Medical Center Amsterdam, 1081 HL Amsterdam, The Netherlands; Department of Medical Genomics, VU University Medical Center, 1081 HV Amsterdam, The Netherlands; Neuroscience Campus Amsterdam, VU University, 1081 HV Amsterdam, The Netherlands.
| | - Mark A van Buchem
- Leiden Institute for Brain and Cognition, Leiden University, 2300 RC Leiden, The Netherlands; Department of Radiology, Leiden University Medical Center, 2333 ZW Leiden, The Netherlands.
| | - Brenda W Penninx
- Department of Psychiatry, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands; Department of Psychiatry, VU University Medical Center Amsterdam, 1081 HL Amsterdam, The Netherlands; Neuroscience Campus Amsterdam, VU University, 1081 HV Amsterdam, The Netherlands.
| | - Dick J Veltman
- Department of Psychiatry, VU University Medical Center Amsterdam, 1081 HL Amsterdam, The Netherlands; Neuroscience Campus Amsterdam, VU University, 1081 HV Amsterdam, The Netherlands.
| | - André Aleman
- Neuroimaging Center, Department of Neuroscience, University Medical Center Groningen and University of Groningen, 9713 AW Groningen, The Netherlands; Department of Psychology, University of Groningen, 9712 TS Groningen, The Netherlands.
| |
Collapse
|
30
|
Opmeer EM, Kortekaas R, van Tol MJ, van der Wee NJA, Woudstra S, van Buchem MA, Penninx BW, Veltman DJ, Aleman A. Influence of COMT val158met genotype on the depressed brain during emotional processing and working memory. PLoS One 2013; 8:e73290. [PMID: 24069183 PMCID: PMC3772077 DOI: 10.1371/journal.pone.0073290] [Citation(s) in RCA: 55] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2013] [Accepted: 07/19/2013] [Indexed: 12/29/2022] Open
Abstract
Major depressive disorder (MDD) has been associated with abnormal prefrontal-limbic interactions and altered catecholaminergic neurotransmission. The val158met polymorphism on the catechol-O-methyltransferase (COMT) gene has been shown to influence prefrontal cortex (PFC) activation during both emotional processing and working memory (WM). Although COMT-genotype is not directly associated with MDD, it may affect MDD pathology by altering PFC activation, an endophenotype associated with both COMT and MDD. 125 participants, including healthy controls (HC, n=28) and MDD patients were genotyped for the COMT val158met polymorphism and underwent functional magnetic resonance imaging (fMRI-neuroimaging) during emotion processing (viewing of emotional facial expressions) and a WM task (visuospatial planning). Within HC, we observed a positive correlation between the number of met-alleles and right inferior frontal gyrus activation during emotional processing, whereas within patients the number of met-alleles was not correlated with PFC activation. During WM a negative correlation between the number of met-alleles and middle frontal gyrus activation was present in the total sample. In addition, during emotional processing there was an effect of genotype in a cluster including the amygdala and hippocampus. These results demonstrate that COMT genotype is associated with relevant endophenotypes for MDD. In addition, presence of MDD only interacts with genotype during emotional processing and not working memory.
Collapse
Affiliation(s)
- Esther M. Opmeer
- Neuroimaging Center, Department of Neuroscience, University Medical Center Groningen and University of Groningen, Groningen, The Netherlands
- * E-mail:
| | - Rudie Kortekaas
- Neuroimaging Center, Department of Neuroscience, University Medical Center Groningen and University of Groningen, Groningen, The Netherlands
| | - Marie-José van Tol
- Neuroimaging Center, Department of Neuroscience, University Medical Center Groningen and University of Groningen, Groningen, The Netherlands
| | - Nic J. A. van der Wee
- Department of Psychiatry, Leiden University Medical Center, Leiden University, Leiden, The Netherlands
- Leiden Institute for Brain and Cognition, Leiden University, Leiden, The Netherlands
| | - Saskia Woudstra
- Department of Psychiatry, Leiden University Medical Center, Leiden University, Leiden, The Netherlands
- Leiden Institute for Brain and Cognition, Leiden University, Leiden, The Netherlands
- Department of Psychiatry, VU University Medical Center, Amsterdam, The Netherlands
- Department of Medical Genomics, VU University Medical Center, Amsterdam, The Netherlands
- Neuroscience Campus Amsterdam, VU University, Amsterdam, The Netherlands
- Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands
| | - Mark A. van Buchem
- Leiden Institute for Brain and Cognition, Leiden University, Leiden, The Netherlands
- Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands
| | - Brenda W. Penninx
- Department of Psychiatry, Leiden University Medical Center, Leiden University, Leiden, The Netherlands
- Department of Psychiatry, VU University Medical Center, Amsterdam, The Netherlands
- Neuroscience Campus Amsterdam, VU University, Amsterdam, The Netherlands
| | - Dick J. Veltman
- Department of Psychiatry, VU University Medical Center, Amsterdam, The Netherlands
- Neuroscience Campus Amsterdam, VU University, Amsterdam, The Netherlands
| | - André Aleman
- Neuroimaging Center, Department of Neuroscience, University Medical Center Groningen and University of Groningen, Groningen, The Netherlands
- Department of Psychology, University of Groningen, Groningen, The Netherlands
| |
Collapse
|
31
|
Opmeer EM, Kortekaas R, van Tol MJ, van der Wee NJA, Woudstra S, van Buchem MA, Penninx BWJH, Veltman DJ, Aleman A. Interaction of neuropeptide Y genotype and childhood emotional maltreatment on brain activity during emotional processing. Soc Cogn Affect Neurosci 2013; 9:601-9. [PMID: 23482625 DOI: 10.1093/scan/nst025] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Neuropeptide Y (NPY) has been associated with stress reactivity in affective disorders and is most densely expressed in the amygdala. An important stressor associated with affective disorders is the experience of childhood emotional maltreatment (CEM). We investigated whether the interaction of NPY risk genotype and CEM would affect brain activation. From The Netherlands Study of Depression and Anxiety, 33 healthy controls and 85 patients with affective disorders were scanned with functional magnetic resonance imaging while making gender decisions of emotional facial expressions. Results showed interactions between genotype and CEM, within carriers of the risk genotype, CEM was associated with higher amygdala activation, whereas CEM did not influence activation in non-risk carriers. In the posterior cingulate cortex (PCC), less activation was seen in those with CEM and the risk genotype, whereas genotype did not influence PCC activation in those without CEM. In addition, those carrying the risk genotype and with experience of CEM made a faster gender decision than those without CEM. Thus, the combined effect of carrying NPY risk genotype and a history of CEM affected amygdala and PCC reactivity, areas related to emotion, self-relevance processing and autobiographical memory. These results are consistent with the notion that the combination of risk genotype and CEM may cause hypervigilance.
Collapse
Affiliation(s)
- Esther M Opmeer
- BCN Neuroimaging Center, University Medical Center Groningen, Antonius Deusinglaan 2, 9713 AW Groningen, The Netherlands.
| | | | | | | | | | | | | | | | | |
Collapse
|
32
|
Groenewold NA, Opmeer EM, de Jonge P, Aleman A, Costafreda SG. Emotional valence modulates brain functional abnormalities in depression: evidence from a meta-analysis of fMRI studies. Neurosci Biobehav Rev 2012. [PMID: 23206667 DOI: 10.1016/j.neubiorev.2012.11.015] [Citation(s) in RCA: 287] [Impact Index Per Article: 23.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Abstract
Models describing the neural correlates of biased emotion processing in depression have focused on increased activation of anterior cingulate and amygdala and decreased activation of striatum and dorsolateral prefrontal cortex. However, neuroimaging studies investigating emotion processing in depression have reported inconsistent results. This meta-analysis integrates these findings and examines whether emotional valence modulates such abnormalities. A systematic literature search identified 26 whole-brain and 18 region-of-interest studies. Peak coordinates and effect sizes were combined in an innovative parametric meta-analysis. Opposing effects were observed in the amygdala, striatum, parahippocampal, cerebellar, fusiform and anterior cingulate cortex, with depressed subjects displaying hyperactivation for negative stimuli and hypoactivation for positive stimuli. Anterior cingulate activity was also modulated by facial versus non-facial stimuli, in addition to emotional valence. Depressed subjects also showed reduced activity in left dorsolateral prefrontal cortex for negative stimuli and increased activity in orbitofrontal cortex for positive stimuli. Emotional valence is a moderator of neural abnormalities in depression, and therefore a critical feature to consider in models of emotional dysfunction in depression.
Collapse
Affiliation(s)
- Nynke A Groenewold
- BCN Neuroimaging Center, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
| | | | | | | | | |
Collapse
|
33
|
Woudstra S, Bochdanovits Z, van Tol MJ, Veltman DJ, Zitman FG, van Buchem MA, van der Wee NJ, Opmeer EM, Demenescu LR, Aleman A, Penninx BW, Hoogendijk WJ. Piccolo genotype modulates neural correlates of emotion processing but not executive functioning. Transl Psychiatry 2012; 2:e99. [PMID: 22832909 PMCID: PMC3337071 DOI: 10.1038/tp.2012.29] [Citation(s) in RCA: 41] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/25/2022] Open
Abstract
Major depressive disorder (MDD) is characterized by affective symptoms and cognitive impairments, which have been associated with changes in limbic and prefrontal activity as well as with monoaminergic neurotransmission. A genome-wide association study implicated the polymorphism rs2522833 in the piccolo (PCLO) gene--involved in monoaminergic neurotransmission--as a risk factor for MDD. However, the role of the PCLO risk allele in emotion processing and executive function or its effect on their neural substrate has never been studied. We used functional magnetic resonance imaging (fMRI) to investigate PCLO risk allele carriers vs noncarriers during an emotional face processing task and a visuospatial planning task in 159 current MDD patients and healthy controls. In PCLO risk allele carriers, we found increased activity in the left amygdala during processing of angry and sad faces compared with noncarriers, independent of psychopathological status. During processing of fearful faces, the PCLO risk allele was associated with increased amygdala activation in MDD patients only. During the visuospatial planning task, we found no genotype effect on performance or on BOLD signal in our predefined areas as a function of increasing task load. The PCLO risk allele was found to be specifically associated with altered emotion processing, but not with executive dysfunction. Moreover, the PCLO risk allele appears to modulate amygdala function during fearful facial processing in MDD and may constitute a possible link between genotype and susceptibility for depression via altered processing of fearful stimuli. The current results may therefore aid in better understanding underlying neurobiological mechanisms in MDD.
Collapse
Affiliation(s)
- S Woudstra
- Department of Psychiatry, VU University Medical Center, Amsterdam, The Netherlands.
| | - Z Bochdanovits
- Department of Medical Genomics, VU University Medical Center, Amsterdam, The Netherlands,Neuroscience Campus Amsterdam, VU University, Amsterdam, The Netherlands
| | - M-J van Tol
- BCN Neuroimaging Center and Department of Neuroscience, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands,Leibniz Institute for Neurobiology, Otto von Guericke University, Magdeburg, Germany
| | - D J Veltman
- Department of Psychiatry, VU University Medical Center, Amsterdam, The Netherlands,Neuroscience Campus Amsterdam, VU University, Amsterdam, The Netherlands
| | - F G Zitman
- Department of Psychiatry, Leiden University Medical Center, Leiden, The Netherlands
| | - M A van Buchem
- Leiden Institute for Brain and Cognition, Leiden University, Leiden, The Netherlands,Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands
| | - N J van der Wee
- Department of Psychiatry, Leiden University Medical Center, Leiden, The Netherlands,Leiden Institute for Brain and Cognition, Leiden University, Leiden, The Netherlands
| | - E M Opmeer
- BCN Neuroimaging Center and Department of Neuroscience, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
| | - L R Demenescu
- BCN Neuroimaging Center and Department of Neuroscience, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands,Department of Psychiatry and Psychotherapy, RWTH Aachen University, Aachen, Germany
| | - A Aleman
- BCN Neuroimaging Center and Department of Neuroscience, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands,Department of Psychology, University of Groningen, Groningen, The Netherlands
| | - B W Penninx
- Department of Psychiatry, VU University Medical Center, Amsterdam, The Netherlands,Department of Psychiatry, Leiden University Medical Center, Leiden, The Netherlands,Neuroscience Campus Amsterdam, VU University, Amsterdam, The Netherlands,BCN Neuroimaging Center and Department of Neuroscience, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
| | - W J Hoogendijk
- Department of Psychiatry, VU University Medical Center, Amsterdam, The Netherlands,Neuroscience Campus Amsterdam, VU University, Amsterdam, The Netherlands,Department of Psychiatry, Erasmus MC, Rotterdam, The Netherlands
| |
Collapse
|